• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年特发性炎症性肌病结局预测的研究路径。

A Path to Prediction of Outcomes in Juvenile Idiopathic Inflammatory Myopathy.

机构信息

School of Medicine, Duke University, Durham, NC, United States.

Division of Pediatric Rheumatology, Department of Pediatrics, Duke University, Durham, NC, United States.

出版信息

Front Immunol. 2019 Apr 2;10:638. doi: 10.3389/fimmu.2019.00638. eCollection 2019.

DOI:10.3389/fimmu.2019.00638
PMID:31001260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6454149/
Abstract

Humans have an innate desire to observe and subsequently dissect an event into component pieces in an effort to better characterize the event. We then examine these pieces individually and in combinations using this information to determine the outcome of future similar events and the likelihood of their recurrence. Practically, this attempt to foretell an occurrence and predict its outcomes is evident in multiple disciplines ranging from meteorology to sociologic studies. In this manuscript we share the historical and present-day tools to predict course and outcome in juvenile idiopathic inflammatory myopathy including clinical features, testing, and biomarkers. Further we discuss considerations for building more complex predictive models of outcome especially in diseases such as juvenile idiopathic inflammatory myopathy where patients numbers are low. Many of the barriers to developing risk prediction models for juvenile idiopathic inflammatory myopathy outcomes have improved with many remaining challenges being addressed.

摘要

人类有一种天生的欲望,即观察事物,并将其随后分解为各个组成部分,以更好地描述该事件。然后,我们使用这些信息单独检查这些部分,并将它们组合起来,以确定未来类似事件的结果以及它们再次发生的可能性。实际上,这种试图预测事件并预测其结果的尝试在从气象学到社会学研究等多个学科中都很明显。在本文中,我们分享了预测幼年特发性关节炎相关肌炎病程和结局的历史和现代工具,包括临床特征、检测和生物标志物。此外,我们还讨论了构建更复杂的预后预测模型的注意事项,特别是在幼年特发性关节炎相关肌炎等患者人数较少的疾病中。许多开发幼年特发性关节炎相关肌炎结局风险预测模型的障碍已经得到改善,许多仍然存在的挑战也正在得到解决。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a449/6454149/8544286f105f/fimmu-10-00638-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a449/6454149/8544286f105f/fimmu-10-00638-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a449/6454149/8544286f105f/fimmu-10-00638-g0001.jpg

相似文献

1
A Path to Prediction of Outcomes in Juvenile Idiopathic Inflammatory Myopathy.青少年特发性炎症性肌病结局预测的研究路径。
Front Immunol. 2019 Apr 2;10:638. doi: 10.3389/fimmu.2019.00638. eCollection 2019.
2
The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes.青少年特发性炎性肌病:发病机制、临床及自身抗体表型与预后
J Intern Med. 2016 Jul;280(1):24-38. doi: 10.1111/joim.12444. Epub 2016 Mar 30.
3
Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: Clinical features and treatment outcomes in a Chinese cohort.伴抗线粒体抗体的特发性炎性肌病:中国队列的临床特征和治疗结局。
Neuromuscul Disord. 2019 Jan;29(1):5-13. doi: 10.1016/j.nmd.2018.11.004. Epub 2018 Nov 22.
4
Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.基于临床表现和肌炎特异性自身抗体的特发性炎性肌病新分类系统的建立。
JAMA Neurol. 2018 Dec 1;75(12):1528-1537. doi: 10.1001/jamaneurol.2018.2598.
5
The Clinical Features of Myositis-Associated Autoantibodies: a Review.肌炎相关自身抗体的临床特征:综述。
Clin Rev Allergy Immunol. 2017 Feb;52(1):45-57. doi: 10.1007/s12016-015-8513-8.
6
Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.特发性炎性肌病中的自身抗体:临床及病理生理意义的最新进展
Curr Opin Rheumatol. 2007 Nov;19(6):523-9. doi: 10.1097/BOR.0b013e3282f01a8c.
7
Myositis in clinical practice-relevance of new antibodies.临床实践中的肌炎——新抗体的相关性。
Best Pract Res Clin Rheumatol. 2018 Dec;32(6):887-901. doi: 10.1016/j.berh.2019.03.012. Epub 2019 Apr 17.
8
[New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis].[青少年及成人型肌炎中肌炎特异性及相关性自身抗体的新见解]
Orv Hetil. 2016 Jul;157(30):1179-84. doi: 10.1556/650.2016.30404.
9
Discovery of new biomarkers of idiopathic inflammatory myopathy.特发性炎性肌病新生物标志物的发现
Clin Chim Acta. 2015 Apr 15;444:117-25. doi: 10.1016/j.cca.2015.02.007. Epub 2015 Feb 11.
10
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis.意大利多发性肌炎和皮肌炎患者的肌炎特异性自身抗体及其与恶性肿瘤的关联
Clin Rheumatol. 2017 Feb;36(2):469-475. doi: 10.1007/s10067-016-3453-0. Epub 2016 Oct 20.

引用本文的文献

1
Incorporating circulating cytokines into the idiopathic inflammatory myopathy subclassification toolkit.将循环细胞因子纳入特发性炎性肌病的分类工具中。
Front Med (Lausanne). 2023 Mar 16;10:1130614. doi: 10.3389/fmed.2023.1130614. eCollection 2023.
2
Urine proteomics by mass spectrometry identifies proteins involved in key pathogenic pathways in patients with juvenile dermatomyositis.质谱法尿液蛋白质组学鉴定出少年皮肌炎患者关键致病途径中的相关蛋白。
Rheumatology (Oxford). 2023 Sep 1;62(9):3161-3168. doi: 10.1093/rheumatology/kead033.
3
Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib.

本文引用的文献

1
Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study.在幼年型皮肌炎的四种疾病活动参数联合模型中观察到的临床体征和症状:一项前瞻性、纵向、多中心队列研究。
Arthritis Res Ther. 2018 Aug 15;20(1):180. doi: 10.1186/s13075-018-1687-8.
2
Juvenile Idiopathic Inflammatory Myopathies.幼年特发性炎性肌病
Pediatr Clin North Am. 2018 Aug;65(4):739-756. doi: 10.1016/j.pcl.2018.04.006.
3
Juvenile dermatomyositis: Latest advances.幼年特发性关节炎:最新进展。
使用托法替布治疗抗MDA5自身抗体阳性的青少年皮肌炎。
Brain. 2019 Nov 1;142(11):e59. doi: 10.1093/brain/awz293.
Best Pract Res Clin Rheumatol. 2017 Aug;31(4):535-557. doi: 10.1016/j.berh.2017.12.003. Epub 2018 Jan 10.
4
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.边缘结构模型显示环磷酰胺治疗重症幼年皮肌炎的疗效和安全性。
Arthritis Rheumatol. 2018 May;70(5):785-793. doi: 10.1002/art.40418. Epub 2018 Mar 25.
5
Development and Testing of a Hybrid Measure of Muscle Strength in Juvenile Dermatomyositis for Use in Routine Care.发展和测试幼年型皮肌炎肌肉力量的混合测量方法,以便在常规护理中使用。
Arthritis Care Res (Hoboken). 2018 Sep;70(9):1312-1319. doi: 10.1002/acr.23491. Epub 2018 Aug 12.
6
Predictors of changes in disease activity among children with juvenile dermatomyositis enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry.幼年特发性关节炎和风湿病研究联盟(CARRA)遗产登记处入组的幼年皮肌炎患儿疾病活动度变化的预测因素。
Clin Rheumatol. 2018 Apr;37(4):1011-1015. doi: 10.1007/s10067-017-3901-5. Epub 2017 Nov 23.
7
Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.制定青少年皮肌炎临床应用共识核心数据集,以支持研究。
Ann Rheum Dis. 2018 Feb;77(2):241-250. doi: 10.1136/annrheumdis-2017-212141. Epub 2017 Oct 30.
8
Using multi-omics methods to understand dermatomyositis/polymyositis.利用多组学方法了解皮肌炎/多发性肌炎。
Autoimmun Rev. 2017 Oct;16(10):1044-1048. doi: 10.1016/j.autrev.2017.07.021. Epub 2017 Aug 1.
9
Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.青少年起病的肌炎中的自身抗体:在一个大型英国队列中的诊断价值及其相关临床表型。
J Autoimmun. 2017 Nov;84:55-64. doi: 10.1016/j.jaut.2017.06.007. Epub 2017 Jun 26.
10
Modelling disease activity in juvenile dermatomyositis: A Bayesian approach.建模幼年特发性皮肌炎的疾病活动度:贝叶斯方法。
Stat Methods Med Res. 2019 Jan;28(1):35-49. doi: 10.1177/0962280217713233. Epub 2017 Jun 7.